Table: Kissei Pharm -2021/22 group results

Kissei Pharmaceutical

10/05/2022 07:00

May 10 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           65.38           69.04          68.00         31.00    
               (-5.3 pct)      (+9.2 pct)     (+4.0 pct)    (-4.3 pct)  
  Operating     loss 1.40          1.51           2.80       loss 1.30  
                               (-19.0 pct)                              
  Recurring      562 mln           3.48           4.40     loss 500 mln 
               (-83.8 pct)     (+43.1 pct)   (+682.1 pct)               
  Net
  Net             12.92            5.29          10.00          3.00    
              (+144.5 pct)     (+87.6 pct)    (-22.6 pct)   (-47.1 pct) 
  EPS          280.20 yen      113.25 yen     216.85 yen     65.05 yen  
  Ann Div       56.00 yen       54.00 yen      80.00 yen                
  -Q2 Div       28.00 yen       27.00 yen      40.00 yen                
  -Q4 Div       28.00 yen       27.00 yen      40.00 yen                
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T